IBS affects 10-15% of the global population. It's not "just stress" — it's a complex disorder of the gut-brain axis with measurable biological markers.
The IBS Triad
IBS has three interconnected drivers:
- Visceral hypersensitivity — the gut's pain threshold is lowered
- Dysmotility — too fast (diarrhea) or too slow (constipation)
- Gut-brain axis dysfunction — bidirectional communication breakdown
Traditional treatment targets ONE of these. Anti-spasmodics for pain. Loperamide for diarrhea. Fiber for constipation. None address the underlying inflammation driving all three.
The Micro-Inflammation Discovery
Recent research shows IBS patients have measurable micro-inflammation:
- Increased mast cells in intestinal mucosa
- Elevated pro-inflammatory cytokines
- Altered microbiome composition
- Low-grade NF-κB activation
This isn't "all in your head." It's measurable, biological, and treatable.
Ginger: The Multi-Target Approach
| IBS Problem | Ginger Mechanism |
|---|---|
| Bloating | Prokinetic — accelerates gastric emptying |
| Visceral pain | 5-HT3 antagonism (same target as alosetron) |
| Spasm | Smooth muscle relaxation |
| Micro-inflammation | Intestinal NF-κB inhibition |
| Anxiety component | BDNF + cortisol modulation (gut-brain axis) |
| Dysbiosis | Prebiotic effect on microbiome diversity |
Six mechanisms from one compound system, addressing all three drivers simultaneously.
The Product
INTI — zero sugar, organic ginger + turmeric + black pepper. The prokinetic effect alone makes it worth trying for IBS bloating. The anti-inflammatory and gut-brain effects are bonuses.
When a disease has three drivers, you need a solution that addresses all three. Not three separate drugs for each one.
Top comments (0)